Akebia Therapeutics Inc (AKBA) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Akebia Therapeutics Inc   (NASDAQ: AKBA)
 

Akebia Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, Akebia Therapeutics Inc 's inventory turnover ratio sequentially decreased to 2.76 in the third quarter 2026, unsurprisingly, as the Akebia Therapeutics Inc markets continue to deteriorate, and AKBA's faces growing challenges to bring down its inventories. Akebia Therapeutics Inc 's average inventory processing period in the Sep 30 2026 quarter, has increased to 132 days, from 123 days, in the Jun 30 2026 quarter.

Within Healthcare sector 135 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1264 in the second quarter 2026, to 1316.

AKBA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Akebia Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AKBA Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 0.32 % -22.09 % -34.14 % -3.9 % -9.03 %
Y / Y Cost of Sales Growth -32.2 % 5.09 % 61.18 % -38.45 % -33.74 %
Inventory Turnover Ratio (TTM) 2.76 2.96 2.76 2.23 2.65
AKBA's Total Ranking # 1316 # 1264 # 925 # 762 #
Average inventory processing period 132 123 132 163 138
Seq. Inventory Growth 43.66 % 0.17 % -16.75 % -16.27 % 11.58 %
Seq. Cost of Sales Growth -38.97 % -15.18 % -1.95 % 33.59 % -5.4 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 33
Healthcare Sector # 136
Overall Market # 1316

Inventory Turnover Ratio Statistics
High Average Low
4.06 2.81 0.98
(Mar 31 2021)   (Sep 30 2019)



AKBA Company Profile >> Back to AKBA Efficiency Comparisons >> Compare AKBA Inventory Turnover Ratio to its Competitors

Financial Statements
Akebia Therapeutics Inc 's Inventories $ 19 Millions Visit AKBA's Balance sheet
Akebia Therapeutics Inc 's Cost of Revenues TTM $ 42 Millions Visit AKBA's Income Statement
What are AKBA's Sales? Visit AKBA's Sales by Segment

Other Inventory Turnover Ratios
Akebia Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AKBA's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AKBA's Competitors
Inventory Turnover Ratio for AKBA's Suppliers
Inventory Turnover Ratio for AKBA's Customers

You may also want to know
AKBA's Sales Growth Rates AKBA's Pe Price to earnings ratio AKBA's Receivables Turnover Ratio AKBA's Stock Quote
AKBA's Net Income Growth Rates AKBA's Ps Price to Sales ratio AKBA's Sales per Employee AKBA's Asset Turnover Ratio
AKBA's Net Margin AKBA's Pb Price to Book ratio AKBA's Financial Strength Ratios AKBA's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Transmedics Group Inc   5.70 $ 301.220  Millions$ 53  Millions
Bristol myers Squibb Company  5.65 $ 15,389.000  Millions$ 2,722  Millions
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Cryoport inc   4.60 $ 102.157  Millions$ 22  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Exelixis Inc   3.49 $ 93.324  Millions$ 27  Millions
Abbvie Inc   3.40 $ 17,346.000  Millions$ 5,108  Millions
Gilead Sciences Inc   3.30 $ 6,219.000  Millions$ 1,884  Millions
Iovance Biotherapeutics inc   3.21 $ 177.232  Millions$ 55  Millions
Teva Pharmaceutical Industries Limited  3.16 $ 8,011.000  Millions$ 2,537  Millions
Msa Safety Inc  3.00 $ 1,063.235  Millions$ 354  Millions
Mimedx Group Inc   2.98 $ 70.562  Millions$ 24  Millions
Ligand Pharmaceuticals Incorporated  2.93 $ 34.495  Millions$ 12  Millions
Neogen Corporation  2.89 $ 464.774  Millions$ 161  Millions
Ani Pharmaceuticals Inc  2.87 $ 405.540  Millions$ 142  Millions
Zevra Therapeutics Inc   2.82 $ 6.736  Millions$ 2  Millions
Biomerica Inc   2.65 $ 4.297  Millions$ 2  Millions
Dexcom Inc   2.65 $ 1,867.500  Millions$ 705  Millions
Dentsply Sirona Inc   2.65 $ 1,769.000  Millions$ 668  Millions

Date modified: 2026-11-06T12:59:24+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.